Identification of self-growth-inhibiting compounds lauric acid and 7-(Z)-tetradecenoic acid from Helicobacter pylori

Microbiology
Shinpei YamashitaMasakatsu Shibasaki

Abstract

Helicobacter pylori growth medium is usually supplemented with horse serum (HS) or FCS. However, cyclodextrin derivatives or activated charcoal can replace serum. In this study, we purified self-growth-inhibiting (SGI) compounds from H. pylori growth medium. The compounds were recovered from porous resin, Diaion HP-20, which was added to the H. pylori growth medium instead of known supplements. These SGI compounds were also identified from 2,6-di-O-methyl-β-cyclodextrin, which was supplemented in a pleuropneumonia-like organisms broth. The growth-inhibiting compounds were identified as lauric acid (LA) and 7-(Z)-tetradecenoic acid [7-(Z)-TDA]. Although several fatty acids had been identified in H. pylori, these specific compounds were not previously found in this species. However, we confirmed that these fatty acids were universally present in the cultivation medium of the H. pylori strains examined in this study. A live/dead assay carried out without HS indicated that these compounds were bacteriostatic; however, no significant growth-inhibiting effect was observed against other tested bacterial species that constituted the indigenous bacterial flora. These findings suggested that LA and 7-(Z)-TDA might play important roles in...Continue Reading

References

May 1, 1990·Journal of Clinical Microbiology·S L Hazell, D Y Graham
May 1, 1990·Journal of Clinical Microbiology·G GeisW Opferkuch
Jul 1, 1986·The Journal of Infectious Diseases·H R Knapp, M A Melly
May 1, 1986·Prostaglandins, Leukotrienes, and Medicine·P BernardiM Capelli
Apr 1, 1987·Journal of Clinical Microbiology·G E Buck, J S Smith
Nov 1, 1987·Journal of Clinical Microbiology·D R MorganW G Kraft
Jun 19, 1973·Biochemical and Biophysical Research Communications·J G Batchelor, J E Cronan
Jul 1, 1972·Antimicrobial Agents and Chemotherapy·J J KabaraJ P Truant
Jun 15, 1994·Annals of Internal Medicine·A NomuraM J Blaser
Apr 1, 1995·Journal of Clinical Microbiology·P E Coudron, C W Stratton
Dec 1, 1993·Journal of Clinical Microbiology·P H Edelstein, M A Edelstein
Aug 1, 1993·Journal of Clinical Pathology·H X XiaC A O'Morain
Jan 1, 1993·Journal of Clinical Microbiology·R OlivieriJ Aziz
Jan 25, 1997·Lancet·C S GoodwinT C Northfield
Dec 12, 1997·Gastroenterology·D R Cave
Feb 24, 2001·Epidemiologic Reviews·L M Brown
Sep 27, 2002·Applied and Environmental Microbiology·Hiroaki InoueShohei Sakuda
May 3, 2003·FEMS Immunology and Medical Microbiology·Cynthia Q SunAnthony M Roberton
Jan 21, 2004·Molecular Microbiology·Lian-Hui WangLian-Hui Zhang
Oct 22, 2009·FEMS Microbiology Letters·Hirofumi ShimomuraYoshikazu Hirai
Jul 27, 2010·Applied and Environmental Microbiology·Melissa Garren, Farooq Azam
Nov 18, 2010·The Journal of Antibiotics·Ruri TanakaTohru Dairi
Mar 13, 2012·Helicobacter·Luisa F Jiménez-SotoRainer Haas
Jul 26, 2012·Molecular Pharmaceutics·Marygorret ObonyoLiangfang Zhang
Jan 10, 2013·MBio·Ellen D BeaulieuSteven Lindow
Jan 23, 2014·International Journal of Medical Microbiology : IJMM·Marta CorreiaJosé C Machado

❮ Previous
Next ❯

Citations

Apr 3, 2019·Antimicrobial Agents and Chemotherapy·Yanqiang HuangHongkai Bi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.